Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clearside Biomedi (NQ: CLSD )

1.330 +0.060 (+4.72%)
Streaming Delayed Price Updated: 3:29 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 161,258
Open 1.300
Bid (Size) 1.290 (34)
Ask (Size) 1.320 (7)
Prev. Close 1.270
Today's Range 1.270 - 1.360
52wk Range 0.6501 - 2.120
Shares Outstanding 61,666,130
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
7 Top Stocks Under $7
Stocks under $7 have greater potential for substantial gains because they start off with lower valuations. Here are some of the best now. 
Via InvestorPlace

Performance

YTD
+3.10%
+3.10%
1 Month
-15.82%
-15.82%
3 Month
+6.40%
+6.40%
6 Month
+74.31%
+74.31%
1 Year
+35.73%
+35.73%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Clearside Biomedical: Q4 Earnings Insights
Via Benzinga
Preview: Clearside Biomedical's Earnings
Via Benzinga
Clearside Biomedical: Q3 Earnings Insights
Via Benzinga
Clearside Biomedical's Earnings: A Preview
Via Benzinga
What 8 Analyst Ratings Have To Say About Clearside Biomedical
Via Benzinga
Earnings Scheduled For March 12, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Clearside Biomedical: Q1 Earnings Insights
Via Benzinga
What 6 Analyst Ratings Have To Say About Clearside Biomedical
Via Benzinga
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Top 5 Health Care Stocks That May Crash This Month
Via Benzinga
Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness
Via Benzinga
Over $2M Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For November 13, 2023
Via Benzinga
3 Cheap Stocks to Buy Under $1 in October 2023
Via InvestorPlace
Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.